Lipocine (LPCN) Institutional Ownership $2.73 +0.05 (+1.87%) Closing price 04:00 PM EasternExtended Trading$2.68 -0.06 (-2.01%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$15.85KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.98K Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673% 2/12/2025Geode Capital Management LLC57,464$280K0.0%+6.0%1.074% 8/9/2024Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480% 8/9/2024Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222% 1/29/2024Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% 5/4/2023Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023Wealthspan Partners LLC73,950$29K0.0%N/A0.084% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 2/2/2023Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021Principal Financial Group Inc.20,382$29K0.0%N/A0.023% (Data available from 1/1/2016 forward) LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: Geode Capital Management LLC ($280K), Renaissance Technologies LLC ($176K), and Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K).Learn more on Lipocine's institutional investors. What percentage of Lipocine's stock is owned by institutional investors? 9.11% of Lipocine's stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine's stock? The following institutional investors have purchased Lipocine's stock in the last 24 months: Dimensional Fund Advisors LP ($11.87K), Renaissance Technologies LLC ($4.60K), and Geode Capital Management LLC ($3.25K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 3,248 shares in the last 24 months. This purchase volume represents approximately $15.85K in transactions. Which of Lipocine's major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Renaissance Technologies LLC ($4.30K). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 4,300 shares in the last 24 months. This volume of shares sold represents approximately $20.98K in transactions. Related Companies CVM Major Shareholders PEPG Major Shareholders ALGS Major Shareholders DRRX Major Shareholders CELU Major Shareholders NRXP Major Shareholders GANX Major Shareholders DTIL Major Shareholders PRLD Major Shareholders ICCC Major Shareholders This page (NASDAQ:LPCN) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LPCN Stock Alerts